Seitz R C, Fischer K, Stegner H E, Poschmann A
Cancer. 1984 Sep 1;54(5):830-6. doi: 10.1002/1097-0142(19840901)54:5<830::aid-cncr2820540512>3.0.co;2-w.
The Thomsen-Friedenreich antigen (TF-antigen), known as a precursor of the MN-blood-group system, has been suggested as a tumor-associated antigen of breast adenocarcinoma. In order to evaluate the TF-antigen as a tool in the histochemical detection of micrometastases, cryostat sections of 25 breast biopsies and 30 regionary lymph nodes were investigated. The study used a sensitive method for the fluorescent staining of the determining terminal disaccharide sequence of asialoglycophorin A by application of peanut agglutinin (PNA) and fluoresceinisothiocyanate-labeled F(ab')2 fragments of monospecific anti-PNA from rabbits. PNA binding was observed in 91% of the sections of predominantly ductal mammary carcinomas. In normal tissues and hyperplastic lesions, staining patterns were markedly different from that of malignant breast cells, and were confined to secretory glycoproteins. Lymph nodes, with histologically confirmed metastases of mammary carcinomas, showed specific PNA binding in the cytoplasm of tumor cells in 75% of cases. Even single malignant cells were demonstrable, which were not recognized at first by routine light microscopy. Fluorescent staining of lymph nodes, which were tumor-free in repeated histologic examinations, was confined to clearly diagnosible histiocytes in 3 of 15 cases. A sensitive indirect immunofluorescent technique demonstrating PNA binding is proposed to be of considerable value for the detection of single metastatic adenocarcinoma cells of the human breast.
汤姆森 - 弗里德赖希抗原(TF抗原),作为MN血型系统的前体,已被认为是乳腺腺癌的肿瘤相关抗原。为了评估TF抗原作为微转移组织化学检测工具的作用,对25份乳腺活检组织和30个区域淋巴结的冰冻切片进行了研究。该研究采用了一种灵敏的方法,通过应用花生凝集素(PNA)和兔抗PNA单特异性F(ab')2片段的异硫氰酸荧光素标记物,对去唾液酸糖蛋白A的决定性末端二糖序列进行荧光染色。在主要为导管型乳腺癌的91%的切片中观察到PNA结合。在正常组织和增生性病变中,染色模式与恶性乳腺细胞明显不同,且仅限于分泌性糖蛋白。组织学证实有乳腺癌转移的淋巴结,75%的病例在肿瘤细胞的细胞质中显示出特异性PNA结合。甚至单个恶性细胞也能被检测到,而这些细胞最初通过常规光学显微镜无法识别。在15例中有3例反复组织学检查无肿瘤的淋巴结,其荧光染色仅限于可明确诊断的组织细胞。一种显示PNA结合的灵敏间接免疫荧光技术被认为对检测人乳腺的单个转移腺癌细胞具有重要价值。